Lipella Pharmaceuticals Inc. (LIPO): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

$2.9K
Year ended 2024-12-31
$2.9K
Trailing 12 months to 2025-09-30
2023-12-31: $1.7K2024-12-31: $2.9K$2.9K
2023-12-31 Depreciation & Amortization (USD) 2024-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2024-12-31$2.9K+71.3%2025-03-28, From 2024-01-01
2023-12-31$1.7Kn/a2025-03-28, From 2023-01-01